Circassia Group initiated with a Hold at Deutsche Bank

Deutsche Bank initiated coverage of Circassia Group with a Hold rating and 250 GBp price target. The analyst says the company specializes in the manufacture of vectors to deliver genetic material using a range of viruses to enhance the disease-fighting capabilities of donor or patient’s cells.